v3.25.2
Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2025
Accounting Policies [Abstract]  
Schedule of assets and liabilities that are measured at fair value on a recurring basis
              
Description  Level   June 30,
2025
   December 31,
2024
 
       (Unaudited)     
Assets:              
Marketable securities held in Trust Account  1   $56,293,697   $- 
               
Liabilities:              
Over-allotment liability  3   $47,200   $- 
Schedule of ordinary shares subject to redemption
     
Gross proceeds  $55,950,000 
Less:     
Proceeds allocated to public rights   (6,461,922)
Offering costs allocated to redeemable shares   (1,156,982)
Plus:     
Accretion of carrying value to redemption value   517,668 
Ordinary shares subject to possible redemption as of June 30, 2025 (Unaudited)  $48,848,764 
Schedule of determination of the fair value of the over-allotment liability
                               
Valuation date 

No. of

options

   Vesting date  Expiry date  Exercise price   Spot price   Risk-free rate   Volatility 
May 30, 2025   155,000   May 29, 2025  July 13, 2025   9.80    10.01    4.19%   3.4%
June 30, 2025   155,000   May 29, 2025  July 13, 2025   9.80    10.09    4.17%   3.1%
Schedule of Net income (loss) used in the calculation of basic and dilute EPS
        
   For the
Three Months Ended
June 30,
2025
   For the
Six Months Ended
June 30,
2025
 
   (Unaudited)   (Unaudited) 
Net income  $113,309   $38,152 
Less: Accretion of redeemable ordinary shares to redemption value   517,668    517,668 
Net loss including accretion of redeemable ordinary shares to redemption value   (404,359)   (479,516)
Schedule of unaudited condensed statement of operations and comprehensive income
                    
   For the
Three Months Ended
June 30, 2025
   For the
Six Months Ended
June 30, 2025
 
   Redeemable
Ordinary Share
   Non-Redeemable
Ordinary Share
   Redeemable
Ordinary Share
   Non-Redeemable
Ordinary Share
 
   (Unaudited)   (Unaudited) 
Numerators:                    
Allocation of net loss  $(233,655)  $(170,704)  $(201,545)  $(277,971)
Accretion of redeemable ordinary shares to redemption value   517,668    -    517,668    - 
Allocation of net income (loss)  $284,013   $(170,704)  $316,123   $(277,971)
Denominators:                    
Weighted-average ordinary shares outstanding   1,927,167    1,407,954    963,583    1,328,977 
                     
Basic earnings (loss) per share  $0.15   $(0.12)  $0.33   $(0.21)

 

Net income (loss) used in the calculation of diluted EPS is based on the following:

 

           
   For the
Three Months Ended
June 30,
2025
   For the
Six Months Ended
June 30,
2025
 
   (Unaudited)   (Unaudited) 
Net income  $113,309   $38,152 
Less: Accretion of redeemable ordinary shares to redemption value   517,668    517,668 
Less: accretion of ordinary share subject to redemption value of participating securities considered potentially dilutive   12,163    12,163 
Net loss including accretion of redeemable ordinary shares to redemption value   (416,522)   (491,679)

 

Diluted EPS per share presented in the unaudited condensed statement of operations and comprehensive income is based on the following:

 

                     
   For the
Three Months Ended
June 30, 2025
   For the
Six Months Ended
June 30, 2025
 
   Redeemable
Ordinary Share
   Non-Redeemable
Ordinary Share
   Redeemable
Ordinary Share
   Non-Redeemable
Ordinary Share
 
   (Unaudited)   (Unaudited) 
Numerators:                    
Allocation of net loss  $(243,454)  $(173,068)  $(209,938)  $(281,742)
Accretion of redeemable ordinary shares to redemption value   529,831    -    529,831    - 
Allocation of net income (loss)  $286,377   $(173,068)  $319,894   $(281,742)
Denominators:                    
Weighted-average ordinary shares outstanding   1,980,556    1,407,954    990,278    1,328,977 
                     
Diluted earnings (loss) per share  $0.14   $(0.12)  $0.32   $(0.21)